PathologyeLifePeer-reviewed
Evaluation of Gremlin-1 as a therapeutic target in metabolic dysfunction-associated steatohepatitis
Paul Horn, Jenny Norlin, Kasper Almholt…·Philip Noel Newsome
This study evaluates Gremlin-1 as a therapeutic target in MASH fibrosis, finding it upregulated but not amenable to targeting due to its restricted expression and lack of effect on fibrogenesis.